For inquiries or customized services, please reach us at pr@pharmaceutical-era.com
Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, announced its telehealth...
UCB, a global biopharmaceutical company, announced Week 24 data for BIMZELX® (bimekizumab-bkzx) from BE BOLD, building on the study's previously reported Week 16 results, which demonstrated...
Johnson & Johnson announced positive results from a Phase 3 study investigating ICOTYDE® (icotrokinra) in biologic-naïve adults with active psoriatic arthritis (PsA).a,b ICOTYDE is the first and...
Eli Lilly and Company announced an agreement to help expand access to Zepbound (tirzepatide) and Foundayo (orforglipron). Through the agreement, eligible patients who receive a prescription from a...
Roche announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the cobas® eplex respiratory pathogen panel 3 (RP3). Designed for the automated cobas® eplex system, this flexible...
Superpower, the human health company on a mission to enhance and extend human life, announces the launch of Superpower Peptides. Members can now sign up for pre-orders for prescribed peptide...
Wolfspeed, Inc. a global leader in silicon carbide (SiC) technology, today announced the commercial introduction of its proprietary transparent silicon carbide (TSiC™) technology expanding the...
Twist Bioscience Corporation a mid-cap growth and value biotech company, launched Twist MRD Express, custom panels manufactured at scale with a rapid turnaround time starting within one day. Twist...
Sciensus has appointed James Tugendhat OBE as Chief Executive Officer, bringing more than 20 years of leadership experience across healthcare and complex service...
Eastman Kodak Company announced the expansion of its KODAK PHARMACEUTICALS portfolio with the addition of KODAK® Normal Saline, 0.9%. The company also introduced a new U.S.-based online store...
Alchemy 21/12 introduced Oleotide™ — a modular biotechnology platform built around the coordination of biological signals and the conditions that support skin renewal. The company describes its...
CELSET INC., a Korean biotechnology company specializing in medical aesthetics, has launched SOLTOX, its botulinum toxin type A brand, introducing a Korean botulinum toxin brand to the international...